D. E. Shaw & Co., Inc. Lifevantage Corp Transaction History

D. E. Shaw & Co., Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.74 - $6.68 $55,628 - $78,396	-11,736 Reduced 19.84%	47,415 $226,000
Q4 2021 Feb 14, 2022	BUY	$6.15 - $7.68 $3,480 - $4,346	566 Added 0.97%	59,151 $374,000
Q3 2021 Nov 15, 2021	BUY	$6.5 - $8.38 $270,159 - $348,297	41,563 Added 244.17%	58,585 $396,000
Q2 2021 Aug 16, 2021	BUY	$6.9 - $9.59 $117,451 - $163,240	17,022 New	17,022 $125,000
Q1 2021 May 17, 2021	SELL	$8.58 - $10.21 $112,492 - $133,863	-13,111 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.32 - $13.4 $122,194 - $175,687	13,111 New	13,111 $122,000
Q3 2020 Nov 16, 2020	SELL	$12.07 - $15.31 $230,705 - $292,635	-19,114 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.25 - $16.54 $195,918 - $316,145	19,114 New	19,114 $258,000
Q1 2020 May 15, 2020	SELL	$7.91 - $16.96 $90,561 - $194,175	-11,449 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.48 - $15.86 $154,332 - $181,581	11,449 New	11,449 $179,000

3.85M

43.5K

2.3K

Ticker LFVN
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 12,560,000
Market Cap $218M
Description
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.